Fidelity Investments’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Fidelity Investments’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$812K	–	4362
2018 Q3	$812K	Buy	+50,000	New	+$715K	﹤0.01%	2494
2014 Q2	–	Sell	-230,000	Closed	-$4.62M	–	2819
2014 Q1	$4.62M	Buy	+230,000	New	+$4.98M	﹤0.01%	2227

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Fidelity Investments's OXFD Position: Q4 2018 in Review

Fidelity Investments sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2018, closing a stake of 50,000 shares — an estimated $812K sold.

Fidelity Investments first reported a position in OXFD in Q1 2014 and held it in 2 quarters. The position peaked at $4.62M in Q1 2014. 82 funds tracked by Wall St. Rank hold OXFD as of Q4 2018.

Fidelity Investments reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2018 after selling out during the quarter.
Fidelity Investments sold 50,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2018, an estimated $812K.
Fidelity Investments first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2014 and held it in 2 quarters.
Fidelity Investments's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.62M in Q1 2014.
82 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2018.

Based on Fidelity Investments's 13F filing for Q4 2018, filed 13 Feb 2019.